Analysts expect over 2019 rising revenue Sanofi-Aventis, relatively high dividend

Next Monday Sanofi-Aventis will publish its past quarters results. Over the current book year the total revenue will be 36,19 billion euros (consensus estimates). This is slightly more than 2018's revenue of 35,68 billion euros.

Historical revenues and results Sanofi-Aventis plus estimates 2019

financial analysis

The analysts expect for 2019 a net profit of 7,21 billion euros. The majority of the analysts expects for this year a profit per share of 5,77 euros. Based on this the price/earnings-ratio is 13,07.

Huge dividend Sanofi-Aventis

Per share the analysts are expecting a dividend of 3,17 euros per share. The dividend yield is then 4,2 percent. The average dividend yield of the pharmaceutical companies is a poor 0,5 percent.

Recent target prices around 92 euros

The most recent recommendations for the pharmaceutical company are from Jefferies & Co., Deutsche Bank and Liberum.

Sanofi-Aventis's market value equals around 94,54 billion . The Sanofi-Aventis stock was the past 12 months quite unstable. Since last July the stock is 6 percent higher. This year the stock price moved between 71 and 80 euro.

At 10.29 the stock trades 0,66 percent higher at 75,4 euros.

Historical stock prices Sanofi-Aventis2007-2019

financial analysis sanofi-aventis

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.